{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:08:03Z","timestamp":1762884483718,"version":"3.45.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many patients with cancer experience pain related to their disease. Opioids are commonly used for moderate-to-severe cancer-related pain but carry significant side effects that may worsen quality of life. Buprenorphine, a partial mu opioid receptor (MOR) agonist, is increasingly used for the management of cancer-related pain. Although well studied as a treatment for opioid use disorder, its role in managing cancer pain is less understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We aim to systematically gather, assess, and summarize prior studies on the impact of buprenorphine upon cancer-related pain. Cochrane CENTRAL, OVID Medline, EMBASE, EBSCO, and Web of Science will be searched in September 2025 for any studies available to date. Studies involving buprenorphine as an intervention upon cancer-related pain will be included where pain outcomes are measured at two or more timepoints using a validated scale. Exclusions apply to case studies\/series with fewer than five subjects, qualitative studies, conference abstracts, review articles, research protocols, studies solely focused on post-operative pain, and studies not available in English translation. After final selection, study type classification, and data extraction, a quality assessment will be conducted using the Cochrane ROB 2 tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Scale for cohort and case-control studies. The summarized data will be evaluated using Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The primary objective is to fill a knowledge gap by summarizing literature on buprenorphine for cancer pain management, including a broad range of study designs, drug formulations, and dosing. This systematic review aims to provide a comprehensive understanding of buprenorphine\u2019s efficacy and safety in cancer pain management, which could inform clinical practice and future research directions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>This protocol was registered in PROSPERO (CRD42022383591).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-025-02957-2","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:58:21Z","timestamp":1762775901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating buprenorphine to treat cancer pain: a systematic review protocol"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-6415","authenticated-orcid":false,"given":"Rafina","family":"Khateeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2957_CR1","unstructured":"World Health Organization Media Team. Global cancer burden growing, amidst mounting need for services. World Health Organization; 2024 [cited 2024 Oct 7]. Available from:\u00a0https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services."},{"issue":"6","key":"2957_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MHJ van den Beuken- Everdingen","year":"2016","unstructured":"van den Beuken- Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070-1090.e9.","journal-title":"J Pain Symptom Manage"},{"key":"2957_CR3","unstructured":"International Association for the Study of Pain (IASP). Cancer pain. IASP; 2021 [cited 2024 Oct 7]. Available from:\u00a0https:\/\/www.iasp-pain.org\/advocacy\/global-year\/cancer-pain\/."},{"issue":"3","key":"2957_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/cancers15030591","volume":"15","author":"RAH Snijders","year":"2023","unstructured":"Snijders RAH, Brom L, Theunissen M, van den Beuken-van Everdingen MHJ. Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers (Basel). 2023;15(3):591.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2957_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.22.02198","volume":"41","author":"JA Paice","year":"2023","unstructured":"Paice JA, Bohlke K, Barton D, Craig DS, El-Jawahri A, Hershman DL, et al. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol. 2023;41(9):914\u201330.","journal-title":"J Clin Oncol"},{"key":"2957_CR6","unstructured":"American Cancer Society. Facts about cancer pain. American Cancer Society; 2024 [cited 2024 Nov 26]. Available from: https:\/\/www.cancer.org\/cancer\/managing-cancer\/side-effects\/pain\/cancer-pain\/pain-in-people-with-cancer.html."},{"key":"2957_CR7","doi-asserted-by":"crossref","unstructured":"Filipponi C, Masiero M, Pizzoli SFM, Grasso R, Ferrucci R, Pravettoni G. A comprehensive analysis of the cancer chronic pain experience: a narrative review. Cancer Manag Res. 2022;14:2173\u201384. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9288227\/.","DOI":"10.2147\/CMAR.S355653"},{"issue":"4","key":"2957_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/2049463720972730","volume":"15","author":"JP Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves JP, Veiga D, Ara\u00fajo A. Chronic pain, functionality and quality of life in cancer survivors. Br J Pain. 2021;15(4):401\u201310.","journal-title":"Br J Pain"},{"issue":"1","key":"2957_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11214-5","volume":"23","author":"G Joshy","year":"2023","unstructured":"Joshy G, Khalatbari-Soltani S, Soga K, Butow P, Laidsaar-Powell R, Koczwara B, et al. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer. BMC Cancer. 2023;23(1):774.","journal-title":"BMC Cancer"},{"key":"2957_CR10","unstructured":"Gaskin DJ, Richard P. The economic costs of pain in the United States. In: Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): National Academies Press (US); 2011. Appendix C.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92521\/."},{"key":"2957_CR11","unstructured":"World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018. License: CC BY-NC-SA 3.0 IGO."},{"issue":"3","key":"2957_CR12","first-page":"286","volume":"74","author":"C Abdel Shaheed","year":"2024","unstructured":"Abdel Shaheed C, Hayes C, Maher CG, Ballantyne JC, Underwood M, McLachlan AJ, et al. Opioid analgesics for nociceptive cancer pain: a comprehensive review. CA Cancer J Clin. 2024;74(3):286\u2013313.","journal-title":"CA Cancer J Clin"},{"key":"2957_CR13","doi-asserted-by":"crossref","unstructured":"Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al.\u00a0The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop.\u00a0Ann Intern Med. 2015;162 (4):276\u201386. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25581257.","DOI":"10.7326\/M14-2559"},{"key":"2957_CR14","doi-asserted-by":"crossref","unstructured":"Case AA, Kullgren J, Anwar S, Pedraza S, Davis MP. Treating chronic pain with buprenorphine\u2014the practical guide.\u00a0Curr Treat Options Oncol.\u00a02021;22(12):116. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34791564\/.","DOI":"10.1007\/s11864-021-00910-8"},{"key":"2957_CR15","unstructured":"Phillips JK, Ford MA, Bonnie RJ, editors. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): National Academies Press (US); 2017."},{"key":"2957_CR16","first-page":"859","volume":"8","author":"IK Khanna","year":"2015","unstructured":"Khanna IK, Pillarisetti S. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res. 2015;8:859\u201370.","journal-title":"J Pain Res"},{"key":"2957_CR17","doi-asserted-by":"crossref","unstructured":"Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, et al. Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med. 2020;21(4):714\u201323. Available from: https:\/\/academic.oup.com\/painmedicine\/article\/21\/4\/714\/5699282.","DOI":"10.1093\/pm\/pnz356"},{"issue":"10","key":"2957_CR18","volume":"7","author":"N Massaly","year":"2016","unstructured":"Massaly N, Mor\u00f3n JA, Al-Hasani R. A trigger for opioid misuse: chronic pain and stress dysregulate the mesolimbic pathway and kappa opioid system. Front Neurosci. 2016;7(10):480.","journal-title":"Front Neurosci"},{"key":"2957_CR19","doi-asserted-by":"crossref","unstructured":"Shulman M, Wai JM, Nunes EV. Buprenorphine treatment for opioid use disorder: an overview. CNS Drugs. 2019;33(6):567\u201380. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6585403\/.","DOI":"10.1007\/s40263-019-00637-z"},{"key":"2957_CR20","doi-asserted-by":"crossref","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/rr\/rr7103a1.htm.","DOI":"10.15585\/mmwr.rr7103a1"},{"issue":"5","key":"2957_CR21","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/j.jpainsymman.2023.06.022","volume":"66","author":"M Chwistek","year":"2023","unstructured":"Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain? J Pain Symptom Manage. 2023;66(5):e638\u201343.","journal-title":"J Pain Symptom Manage"},{"key":"2957_CR22","doi-asserted-by":"crossref","unstructured":"Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart JS. Buprenorphine for treating cancer pain. Cochrane Database Syst Rev. 2015;2015(3):CD009596. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6513197.","DOI":"10.1002\/14651858.CD009596.pub4"},{"key":"2957_CR23","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors).\u00a0Cochrane handbook for systematic reviews of interventions\u00a0version 6.5. Cochrane, 2024. Available from www.training.cochrane.org\/handbook."},{"key":"2957_CR24","unstructured":"DistillerSR version 2.35. DistillerSR Inc.; 2023. [cited 2024 Nov 15].\u00a0https:\/\/www.distillersr.com\/."},{"key":"2957_CR25","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 2021;372(71). Available from: https:\/\/www.bmj.com\/content\/372\/bmj.n71."},{"key":"2957_CR26","doi-asserted-by":"crossref","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Br Med J. 2011;343:d5928. Available from: https:\/\/www.bmj.com\/content\/343\/bmj.d5928.","DOI":"10.1136\/bmj.d5928"},{"key":"2957_CR27","unstructured":"Wells GA, Wells G, Shea B, Shea B, O\u2019Connell D, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute; 2021 [cited 2024 Nov 15]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2957_CR28","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J. 2008;336(7650):924\u20136. Available from: https:\/\/www.bmj.com\/content\/336\/7650\/924.","DOI":"10.1136\/bmj.39489.470347.AD"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02957-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02957-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02957-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:05:41Z","timestamp":1762884341000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-025-02957-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2957"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02957-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}